CA3053009A1 - Optique, dispositif et systeme d'essai - Google Patents
Optique, dispositif et systeme d'essaiInfo
- Publication number
- CA3053009A1 CA3053009A1 CA3053009A CA3053009A CA3053009A1 CA 3053009 A1 CA3053009 A1 CA 3053009A1 CA 3053009 A CA3053009 A CA 3053009A CA 3053009 A CA3053009 A CA 3053009A CA 3053009 A1 CA3053009 A1 CA 3053009A1
- Authority
- CA
- Canada
- Prior art keywords
- sample
- optical
- optical assembly
- light
- imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003384 imaging method Methods 0.000 claims abstract description 255
- 230000003287 optical effect Effects 0.000 claims description 445
- 238000005286 illumination Methods 0.000 claims description 144
- 125000006850 spacer group Chemical group 0.000 claims description 118
- 239000007788 liquid Substances 0.000 claims description 76
- 239000000835 fiber Substances 0.000 claims description 32
- 239000013307 optical fiber Substances 0.000 claims description 31
- 230000005284 excitation Effects 0.000 claims description 26
- 239000000758 substrate Substances 0.000 claims description 21
- 239000006096 absorbing agent Substances 0.000 claims description 20
- 238000012545 processing Methods 0.000 claims description 19
- 230000037361 pathway Effects 0.000 claims description 16
- 230000005540 biological transmission Effects 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 238000000799 fluorescence microscopy Methods 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 230000000903 blocking effect Effects 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims description 2
- 230000010287 polarization Effects 0.000 claims description 2
- 239000010409 thin film Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 141
- 239000000523 sample Substances 0.000 description 560
- 238000010186 staining Methods 0.000 description 76
- 239000003795 chemical substances by application Substances 0.000 description 61
- 238000001514 detection method Methods 0.000 description 60
- 239000012491 analyte Substances 0.000 description 58
- 210000001519 tissue Anatomy 0.000 description 57
- 238000004422 calculation algorithm Methods 0.000 description 38
- 230000008859 change Effects 0.000 description 30
- 238000003825 pressing Methods 0.000 description 30
- 230000001105 regulatory effect Effects 0.000 description 29
- 238000000151 deposition Methods 0.000 description 26
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 23
- 230000008569 process Effects 0.000 description 23
- -1 reservoirs Substances 0.000 description 22
- 238000012360 testing method Methods 0.000 description 22
- 238000012549 training Methods 0.000 description 21
- 238000010295 mobile communication Methods 0.000 description 20
- 238000003860 storage Methods 0.000 description 18
- 230000009977 dual effect Effects 0.000 description 17
- 239000000427 antigen Substances 0.000 description 16
- 102000036639 antigens Human genes 0.000 description 16
- 108091007433 antigens Proteins 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 238000013461 design Methods 0.000 description 13
- 238000007901 in situ hybridization Methods 0.000 description 13
- 238000003325 tomography Methods 0.000 description 13
- 239000002981 blocking agent Substances 0.000 description 12
- 238000012546 transfer Methods 0.000 description 11
- 101000863856 Homo sapiens Shiftless antiviral inhibitor of ribosomal frameshifting protein Proteins 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 230000008021 deposition Effects 0.000 description 9
- 230000004807 localization Effects 0.000 description 9
- 229960000907 methylthioninium chloride Drugs 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 238000007398 colorimetric assay Methods 0.000 description 8
- 238000013527 convolutional neural network Methods 0.000 description 8
- 238000000386 microscopy Methods 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 238000004737 colorimetric analysis Methods 0.000 description 7
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 6
- 210000002939 cerumen Anatomy 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000010801 machine learning Methods 0.000 description 6
- 239000012188 paraffin wax Substances 0.000 description 6
- 239000008191 permeabilizing agent Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- NALREUIWICQLPS-UHFFFAOYSA-N 7-imino-n,n-dimethylphenothiazin-3-amine;hydrochloride Chemical compound [Cl-].C1=C(N)C=C2SC3=CC(=[N+](C)C)C=CC3=NC2=C1 NALREUIWICQLPS-UHFFFAOYSA-N 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- ZBQZBWKNGDEDOA-UHFFFAOYSA-N eosin B Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC([N+]([O-])=O)=C(O)C(Br)=C1OC1=C2C=C([N+]([O-])=O)C(O)=C1Br ZBQZBWKNGDEDOA-UHFFFAOYSA-N 0.000 description 5
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 5
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
- 230000002055 immunohistochemical effect Effects 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 239000002751 oligonucleotide probe Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- OCKKUZVCJCWWHM-UHFFFAOYSA-L (7-amino-8-methylphenoxazin-3-ylidene)-diethylazanium;dichlorozinc;dichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Zn+2].CC1=C(N)C=C2OC3=CC(=[N+](CC)CC)C=CC3=NC2=C1.CC1=C(N)C=C2OC3=CC(=[N+](CC)CC)C=CC3=NC2=C1 OCKKUZVCJCWWHM-UHFFFAOYSA-L 0.000 description 4
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 4
- JKYKXTRKURYNGW-UHFFFAOYSA-N 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=C(O)C(S(O)(=O)=O)=C2 JKYKXTRKURYNGW-UHFFFAOYSA-N 0.000 description 4
- AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 description 4
- ALJHHTHBYJROOG-UHFFFAOYSA-N 7-(dimethylamino)phenothiazin-3-one Chemical compound C1=CC(=O)C=C2SC3=CC(N(C)C)=CC=C3N=C21 ALJHHTHBYJROOG-UHFFFAOYSA-N 0.000 description 4
- MPVDXIMFBOLMNW-ISLYRVAYSA-N 7-hydroxy-8-[(E)-phenyldiazenyl]naphthalene-1,3-disulfonic acid Chemical compound OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1\N=N\C1=CC=CC=C1 MPVDXIMFBOLMNW-ISLYRVAYSA-N 0.000 description 4
- CKLBXIYTBHXJEH-UHFFFAOYSA-J 75881-23-1 Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cu+2].[N-]1C(N=C2C3=CC=C(CSC(N(C)C)=[N+](C)C)C=C3C(N=C3C4=CC=C(CSC(N(C)C)=[N+](C)C)C=C4C(=N4)[N-]3)=N2)=C(C=C(CSC(N(C)C)=[N+](C)C)C=C2)C2=C1N=C1C2=CC(CSC(N(C)C)=[N+](C)C)=CC=C2C4=N1 CKLBXIYTBHXJEH-UHFFFAOYSA-J 0.000 description 4
- QFIIYGZAUXVPSZ-UHFFFAOYSA-N 8-(2,4-dihydroxy-6-methylanilino)-2-(2,4-dihydroxy-6-methylphenyl)imino-7-hydroxy-1,9-dimethyldibenzofuran-3-one Chemical compound CC1=CC(=CC(=C1NC2=C(C3=C(C=C2O)OC4=CC(=O)C(=NC5=C(C=C(C=C5C)O)O)C(=C43)C)C)O)O QFIIYGZAUXVPSZ-UHFFFAOYSA-N 0.000 description 4
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 4
- XXACTDWGHQXLGW-UHFFFAOYSA-M Janus Green B chloride Chemical compound [Cl-].C12=CC(N(CC)CC)=CC=C2N=C2C=CC(\N=N\C=3C=CC(=CC=3)N(C)C)=CC2=[N+]1C1=CC=CC=C1 XXACTDWGHQXLGW-UHFFFAOYSA-M 0.000 description 4
- WWKGVZASJYXZKN-UHFFFAOYSA-N Methyl violet 2B Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(N)=CC=1)=C1C=CC(=[N+](C)C)C=C1 WWKGVZASJYXZKN-UHFFFAOYSA-N 0.000 description 4
- 239000004218 Orcein Substances 0.000 description 4
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 4
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 4
- AXIKDPDWFVPGOD-UHFFFAOYSA-O [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;2-(2,4,5,7-tetrabromo-3,6-dihydroxyxanthen-10-ium-9-yl)benzoic acid Chemical compound C1=CC(=[N+](C)C)C=C2SC3=CC(N(C)C)=CC=C3N=C21.OC(=O)C1=CC=CC=C1C1=C(C=C(Br)C(O)=C2Br)C2=[O+]C2=C1C=C(Br)C(O)=C2Br AXIKDPDWFVPGOD-UHFFFAOYSA-O 0.000 description 4
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 4
- RZUBARUFLYGOGC-MTHOTQAESA-L acid fuchsin Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=C(N)C(C)=CC(C(=C\2C=C(C(=[NH2+])C=C/2)S([O-])(=O)=O)\C=2C=C(C(N)=CC=2)S([O-])(=O)=O)=C1 RZUBARUFLYGOGC-MTHOTQAESA-L 0.000 description 4
- DGOBMKYRQHEFGQ-UHFFFAOYSA-L acid green 5 Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 DGOBMKYRQHEFGQ-UHFFFAOYSA-L 0.000 description 4
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 4
- JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 4
- QZKHGYGBYOUFGK-UHFFFAOYSA-L azocarmine B Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(S(=O)(=O)[O-])=CC=C1NC(C1=CC(=CC=C1C1=NC2=CC=CC=C22)S([O-])(=O)=O)=CC1=[N+]2C1=CC=CC=C1 QZKHGYGBYOUFGK-UHFFFAOYSA-L 0.000 description 4
- LUERODMRBLNCFK-UHFFFAOYSA-M azocarmine G Chemical compound [Na+].C1=CC(S(=O)(=O)[O-])=CC=C1NC(C1=CC(=CC=C1C1=NC2=CC=CC=C22)S([O-])(=O)=O)=CC1=[N+]2C1=CC=CC=C1 LUERODMRBLNCFK-UHFFFAOYSA-M 0.000 description 4
- BDFZFGDTHFGWRQ-UHFFFAOYSA-N basic brown 1 Chemical compound NC1=CC(N)=CC=C1N=NC1=CC=CC(N=NC=2C(=CC(N)=CC=2)N)=C1 BDFZFGDTHFGWRQ-UHFFFAOYSA-N 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 238000000339 bright-field microscopy Methods 0.000 description 4
- 229960001506 brilliant green Drugs 0.000 description 4
- 235000012730 carminic acid Nutrition 0.000 description 4
- XRPLBRIHZGVJIC-UHFFFAOYSA-L chembl3182776 Chemical compound [Na+].[Na+].NC1=CC(N)=CC=C1N=NC1=CC=C(C=2C=CC(=CC=2)N=NC=2C(=CC3=CC(=C(N=NC=4C=CC=CC=4)C(O)=C3C=2N)S([O-])(=O)=O)S([O-])(=O)=O)C=C1 XRPLBRIHZGVJIC-UHFFFAOYSA-L 0.000 description 4
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- OOYIOIOOWUGAHD-UHFFFAOYSA-L disodium;2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C([O-])C(Br)=C1OC1=C(Br)C([O-])=C(Br)C=C21 OOYIOIOOWUGAHD-UHFFFAOYSA-L 0.000 description 4
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 4
- UKZQEOHHLOYJLY-UHFFFAOYSA-M ethyl eosin Chemical compound [K+].CCOC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 UKZQEOHHLOYJLY-UHFFFAOYSA-M 0.000 description 4
- IDAQSADEMXDTKN-UHFFFAOYSA-L ethyl green Chemical compound [Cl-].[Br-].C1=CC([N+](C)(C)CC)=CC=C1C(C=1C=CC(=CC=1)N(C)C)=C1C=CC(=[N+](C)C)C=C1 IDAQSADEMXDTKN-UHFFFAOYSA-L 0.000 description 4
- MNEJSIQJOSRAAA-UHFFFAOYSA-O ethyl-[4-[[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]-(4-hydroxy-3-sulfophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene]-[(3-sulfophenyl)methyl]azanium Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C=2C=C(C(O)=CC=2)S(O)(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 MNEJSIQJOSRAAA-UHFFFAOYSA-O 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 4
- 229960003988 indigo carmine Drugs 0.000 description 4
- 235000012738 indigotine Nutrition 0.000 description 4
- 239000004179 indigotine Substances 0.000 description 4
- 238000004020 luminiscence type Methods 0.000 description 4
- 229940107698 malachite green Drugs 0.000 description 4
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 4
- 229940012189 methyl orange Drugs 0.000 description 4
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 4
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 4
- 235000019248 orcein Nutrition 0.000 description 4
- AFAIELJLZYUNPW-UHFFFAOYSA-N pararosaniline free base Chemical compound C1=CC(N)=CC=C1C(C=1C=CC(N)=CC=1)=C1C=CC(=N)C=C1 AFAIELJLZYUNPW-UHFFFAOYSA-N 0.000 description 4
- NTGBUUXKGAZMSE-UHFFFAOYSA-N phenyl n-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]carbamate Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(NC(=O)OC=3C=CC=CC=3)=CC=2)CC1 NTGBUUXKGAZMSE-UHFFFAOYSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- CXZRDVVUVDYSCQ-UHFFFAOYSA-M pyronin B Chemical compound [Cl-].C1=CC(=[N+](CC)CC)C=C2OC3=CC(N(CC)CC)=CC=C3C=C21 CXZRDVVUVDYSCQ-UHFFFAOYSA-M 0.000 description 4
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 4
- 108700024661 strong silver Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- YCUVUDODLRLVIC-VPHDGDOJSA-N sudan black b Chemical compound C1=CC(=C23)NC(C)(C)NC2=CC=CC3=C1\N=N\C(C1=CC=CC=C11)=CC=C1\N=N\C1=CC=CC=C1 YCUVUDODLRLVIC-VPHDGDOJSA-N 0.000 description 4
- 229940099373 sudan iii Drugs 0.000 description 4
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 4
- 229950003937 tolonium Drugs 0.000 description 4
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 4
- XOSXWYQMOYSSKB-UHFFFAOYSA-L water blue Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=C(N)C(C)=CC(C(=C2C=CC(C=C2)=NC=2C=CC(=CC=2)S([O-])(=O)=O)C=2C=CC(NC=3C=CC(=CC=3)S(O)(=O)=O)=CC=2)=C1 XOSXWYQMOYSSKB-UHFFFAOYSA-L 0.000 description 4
- 206010050337 Cerumen impaction Diseases 0.000 description 3
- 101000649946 Homo sapiens Vacuolar protein sorting-associated protein 29 Proteins 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000005228 Pericardial Effusion Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 238000001069 Raman spectroscopy Methods 0.000 description 3
- 241000219061 Rheum Species 0.000 description 3
- 102100028290 Vacuolar protein sorting-associated protein 29 Human genes 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000004381 amniotic fluid Anatomy 0.000 description 3
- 210000003567 ascitic fluid Anatomy 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 210000001268 chyle Anatomy 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000013135 deep learning Methods 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005401 electroluminescence Methods 0.000 description 3
- 210000003060 endolymph Anatomy 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000000834 fixative Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 210000004912 pericardial fluid Anatomy 0.000 description 3
- 210000004049 perilymph Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000005424 photoluminescence Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 210000004910 pleural fluid Anatomy 0.000 description 3
- 210000004915 pus Anatomy 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 210000001179 synovial fluid Anatomy 0.000 description 3
- 210000001138 tear Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000004916 vomit Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 102100028175 Abasic site processing protein HMCES Human genes 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 101001006387 Homo sapiens Abasic site processing protein HMCES Proteins 0.000 description 2
- 101100537375 Homo sapiens TMEM107 gene Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 102100036728 Transmembrane protein 107 Human genes 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 238000002310 reflectometry Methods 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
- 102100022210 COX assembly mitochondrial protein 2 homolog Human genes 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102100029203 F-box only protein 8 Human genes 0.000 description 1
- 101100321670 Fagopyrum esculentum FA18 gene Proteins 0.000 description 1
- 238000010867 Hoechst staining Methods 0.000 description 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 101000900446 Homo sapiens COX assembly mitochondrial protein 2 homolog Proteins 0.000 description 1
- 101100280298 Homo sapiens FAM162A gene Proteins 0.000 description 1
- 101100334493 Homo sapiens FBXO8 gene Proteins 0.000 description 1
- 101100257194 Homo sapiens SMIM8 gene Proteins 0.000 description 1
- 101000741917 Homo sapiens Serine/threonine-protein phosphatase 1 regulatory subunit 10 Proteins 0.000 description 1
- 101000911790 Homo sapiens Sister chromatid cohesion protein DCC1 Proteins 0.000 description 1
- 101000631695 Homo sapiens Succinate dehydrogenase assembly factor 3, mitochondrial Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 101100170008 Oryza sativa subsp. japonica DBB1 gene Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102100023788 Protein FAM162A Human genes 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 101100127688 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA1 gene Proteins 0.000 description 1
- 101100127690 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA2 gene Proteins 0.000 description 1
- 241000490025 Schefflera digitata Species 0.000 description 1
- 102100038743 Serine/threonine-protein phosphatase 1 regulatory subunit 10 Human genes 0.000 description 1
- 102100027040 Sister chromatid cohesion protein DCC1 Human genes 0.000 description 1
- 102100024789 Small integral membrane protein 8 Human genes 0.000 description 1
- 102100028996 Succinate dehydrogenase assembly factor 3, mitochondrial Human genes 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 235000012544 Viola sororia Nutrition 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 238000010817 Wright-Giemsa staining Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 1
- 210000005224 forefinger Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000012015 optical character recognition Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052704 radon Inorganic materials 0.000 description 1
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
- 238000012124 rapid diagnostic test Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L9/00—Supporting devices; Holding devices
- B01L9/52—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/0004—Microscopes specially adapted for specific applications
- G02B21/0008—Microscopes having a simple construction, e.g. portable microscopes
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/0004—Microscopes specially adapted for specific applications
- G02B21/002—Scanning microscopes
- G02B21/0024—Confocal scanning microscopes (CSOMs) or confocal "macroscopes"; Accessories which are not restricted to use with CSOMs, e.g. sample holders
- G02B21/0052—Optical details of the image generation
- G02B21/0076—Optical details of the image generation arrangements using fluorescence or luminescence
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/06—Means for illuminating specimens
- G02B21/08—Condensers
- G02B21/12—Condensers affording bright-field illumination
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/16—Microscopes adapted for ultraviolet illumination ; Fluorescence microscopes
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/24—Base structure
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B7/00—Mountings, adjusting means, or light-tight connections, for optical elements
- G02B7/02—Mountings, adjusting means, or light-tight connections, for optical elements for lenses
- G02B7/023—Mountings, adjusting means, or light-tight connections, for optical elements for lenses permitting adjustment
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/50—Constructional details
- H04N23/51—Housings
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/50—Constructional details
- H04N23/55—Optical parts specially adapted for electronic image sensors; Mounting thereof
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/56—Cameras or camera modules comprising electronic image sensors; Control thereof provided with illuminating means
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/57—Mechanical or electrical details of cameras or camera modules specially adapted for being embedded in other devices
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/60—Control of cameras or camera modules
- H04N23/67—Focus control based on electronic image sensor signals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/025—Align devices or objects to ensure defined positions relative to each other
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Signal Processing (AREA)
- Multimedia (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Clinical Laboratory Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Plasma & Fusion (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Microscoopes, Condenser (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
La présente invention concerne, entre autres, des dispositifs et des procédés d'essai simple, rapide et sensible, comprenant l'imagerie.
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762456590P | 2017-02-08 | 2017-02-08 | |
| US201762456504P | 2017-02-08 | 2017-02-08 | |
| US201762456598P | 2017-02-08 | 2017-02-08 | |
| US62/456,504 | 2017-02-08 | ||
| US62/456,590 | 2017-02-08 | ||
| US62/456,598 | 2017-02-08 | ||
| US201762456904P | 2017-02-09 | 2017-02-09 | |
| US201762457133P | 2017-02-09 | 2017-02-09 | |
| US62/456,904 | 2017-02-09 | ||
| US62/457,133 | 2017-02-09 | ||
| US201762459554P | 2017-02-15 | 2017-02-15 | |
| US62/459,554 | 2017-02-15 | ||
| US201762460075P | 2017-02-16 | 2017-02-16 | |
| US201762460062P | 2017-02-16 | 2017-02-16 | |
| US62/460,062 | 2017-02-16 | ||
| US62/460,075 | 2017-02-16 | ||
| PCT/US2018/017504 WO2018148471A2 (fr) | 2017-02-08 | 2018-02-08 | Optique, dispositif et système d'essai |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3053009A1 true CA3053009A1 (fr) | 2018-08-16 |
Family
ID=63107057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3053009A Pending CA3053009A1 (fr) | 2017-02-08 | 2018-02-08 | Optique, dispositif et systeme d'essai |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3580597A4 (fr) |
| JP (1) | JP7177073B2 (fr) |
| CN (2) | CN111465882B (fr) |
| CA (1) | CA3053009A1 (fr) |
| WO (1) | WO2018148471A2 (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4119677B1 (fr) | 2015-04-10 | 2023-06-28 | Spatial Transcriptomics AB | Analyse de plusieurs acides nucléiques spatialement différenciés de spécimens biologiques |
| JP2021535395A (ja) * | 2018-08-28 | 2021-12-16 | エッセンリックス コーポレーション | アッセイ精度向上 |
| USD897555S1 (en) | 2018-11-15 | 2020-09-29 | Essenlix Corporation | Assay card |
| USD898224S1 (en) | 2018-11-15 | 2020-10-06 | Essenlix Corporation | Assay plate with sample landing mark |
| USD898221S1 (en) | 2018-11-15 | 2020-10-06 | Essenlix Corporation | Assay plate |
| USD898939S1 (en) | 2018-11-20 | 2020-10-13 | Essenlix Corporation | Assay plate with sample landing mark |
| USD893469S1 (en) | 2018-11-21 | 2020-08-18 | Essenlix Corporation | Phone holder |
| USD910202S1 (en) | 2018-11-21 | 2021-02-09 | Essenlix Corporation | Assay plate with sample landing mark |
| USD910203S1 (en) | 2018-11-27 | 2021-02-09 | Essenlix Corporation | Assay plate with sample landing mark |
| USD893470S1 (en) | 2018-11-28 | 2020-08-18 | Essenlix Corporation | Phone holder |
| USD912842S1 (en) | 2018-11-29 | 2021-03-09 | Essenlix Corporation | Assay plate |
| US20220025447A1 (en) | 2018-12-10 | 2022-01-27 | 10X Genomics, Inc. | Generating spatial arrays with gradients |
| USD898222S1 (en) | 2019-01-18 | 2020-10-06 | Essenlix Corporation | Assay card |
| CN110297322A (zh) * | 2019-01-21 | 2019-10-01 | 福鼎市一雄光学仪器有限公司 | 内置光纤照明的手机高清近摄放大镜头装置 |
| CN111289443A (zh) * | 2019-07-03 | 2020-06-16 | 无锡市人民医院 | 一种便于进行循环利用的引流液比色卡及其比色方法 |
| EP3997506A4 (fr) * | 2019-07-11 | 2023-08-16 | Sensibility Pty Ltd | Système d'imagerie de téléphone basé sur l'apprentissage automatique et procédé d'analyse |
| WO2021011944A2 (fr) * | 2019-07-18 | 2021-01-21 | Essenlix Corporation | Dosage homogène faisant appel à l'imagerie |
| EP3798614A1 (fr) * | 2019-09-30 | 2021-03-31 | IAssay, Inc. | Dispositifs et plateformes d'analyse multiplex modulaire |
| GB201918948D0 (en) | 2019-12-20 | 2020-02-05 | Oxford Immune Algorithmics Ltd | Portable device for imaging biological sample |
| CN113155555B (zh) * | 2020-01-23 | 2023-04-11 | 天津市政工程设计研究总院有限公司 | 用于模拟混凝土管廊的镁合金模型的制作方法 |
| US11768175B1 (en) | 2020-03-04 | 2023-09-26 | 10X Genomics, Inc. | Electrophoretic methods for spatial analysis |
| EP4153775A1 (fr) | 2020-05-22 | 2023-03-29 | 10X Genomics, Inc. | Mesure spatio-temporelle simultanée de l'expression génique et de l'activité cellulaire |
| EP4162074B1 (fr) | 2020-06-08 | 2024-04-24 | 10X Genomics, Inc. | Méthodes de détermination de marge chirurgicale et méthodes d'utilisation associées |
| WO2021252747A1 (fr) * | 2020-06-10 | 2021-12-16 | 1Ox Genomics, Inc. | Procédés de distribution de fluide |
| US20220020481A1 (en) | 2020-07-20 | 2022-01-20 | Abbott Laboratories | Digital pass verification systems and methods |
| EP4199810A4 (fr) * | 2020-08-23 | 2024-03-13 | My Or Diagnostics Ltd | Appareil et procédé de détermination des taux d'hémoglobine |
| AU2021343507A1 (en) * | 2020-09-18 | 2023-04-06 | 10X Genomics, Inc. | Sample handling apparatus and fluid delivery methods |
| CN112276370B (zh) * | 2020-11-27 | 2021-10-08 | 华中科技大学 | 一种基于空间光调制器的三维码激光标刻方法及系统 |
| WO2022119459A1 (fr) * | 2020-12-03 | 2022-06-09 | Pictor Limited | Dispositif et procédé de détection d'analyte |
| EP4121555A1 (fr) | 2020-12-21 | 2023-01-25 | 10X Genomics, Inc. | Procédés, compositions et systèmes pour capturer des sondes et/ou des codes à barres |
| CN116745679A (zh) * | 2021-01-06 | 2023-09-12 | 斯科普根私人有限公司 | 紧凑型便携式多模式显微镜 |
| WO2022178054A1 (fr) * | 2021-02-18 | 2022-08-25 | Peek Technologies, Inc. | Systèmes de plate-forme de diagnostic configurables et procédés pour effectuer des essais de test chimique |
| CN113984759B (zh) * | 2021-09-24 | 2023-12-12 | 暨南大学 | 一种光学即时检测系统、体液玻片成晶与检测方法 |
| WO2024092682A1 (fr) * | 2022-11-04 | 2024-05-10 | 深圳华大智造科技股份有限公司 | Système optique et procédé de détection |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7372985B2 (en) * | 2003-08-15 | 2008-05-13 | Massachusetts Institute Of Technology | Systems and methods for volumetric tissue scanning microscopy |
| JP2005099786A (ja) * | 2003-08-29 | 2005-04-14 | Olympus Corp | 顕微鏡の光学素子切換装置 |
| DE102004034975A1 (de) * | 2004-07-16 | 2006-02-16 | Carl Zeiss Jena Gmbh | Verfahren zur Erfassung von Bildern einer Probe mit einem Mikroskop |
| JP5080186B2 (ja) * | 2007-09-26 | 2012-11-21 | 富士フイルム株式会社 | 分子分析光検出方法およびそれに用いられる分子分析光検出装置、並びにサンプルプレート |
| EP2227711A4 (fr) * | 2008-01-02 | 2014-01-22 | Univ California | Appareil de télémicroscopie à ouverture numérique élevée |
| EP2633678A4 (fr) * | 2010-10-29 | 2015-05-20 | Univ California | Appareil de type téléphone microscope ou cellscope et procédés d'imagerie |
| EP2656066A4 (fr) * | 2010-12-21 | 2017-11-08 | The Regents of The University of California | Imagerie par fluorescence à grand champ compacte sur un dispositif mobile |
| KR102096455B1 (ko) * | 2013-07-12 | 2020-04-02 | 나우다이아그노스틱스, 인코포레이티드 | 트랜스-비주얼 감도를 가진 범용 신속 진단 테스트 판독기 |
| CN112033962B (zh) * | 2013-12-12 | 2024-01-12 | 梅斯医疗电子系统有限公司 | 家庭测试设备 |
| TWI551269B (zh) * | 2014-03-21 | 2016-10-01 | 財團法人工業技術研究院 | 攜帶型分析裝置以及系統 |
| TWI533025B (zh) * | 2014-07-07 | 2016-05-11 | 億觀生物科技股份有限公司 | 可攜式顯微鏡裝置 |
| CN115989999A (zh) * | 2014-07-24 | 2023-04-21 | 大学健康网络 | 用于诊断目的的数据的收集和分析 |
| JP2016161550A (ja) * | 2015-03-05 | 2016-09-05 | アークレイ株式会社 | 比色測定用アダプタ |
| CN204439554U (zh) * | 2015-03-27 | 2015-07-01 | 华南师范大学 | 智能手机宽场荧光成像器 |
| US10068145B2 (en) * | 2015-07-30 | 2018-09-04 | Fuji Xerox Co., Ltd. | Photographing system configured to hold a pill |
-
2018
- 2018-02-08 CN CN201880020973.8A patent/CN111465882B/zh active Active
- 2018-02-08 WO PCT/US2018/017504 patent/WO2018148471A2/fr unknown
- 2018-02-08 CA CA3053009A patent/CA3053009A1/fr active Pending
- 2018-02-08 EP EP18751754.5A patent/EP3580597A4/fr active Pending
- 2018-02-08 CN CN202310507084.7A patent/CN116794819A/zh active Pending
- 2018-02-08 JP JP2019543054A patent/JP7177073B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN116794819A (zh) | 2023-09-22 |
| EP3580597A2 (fr) | 2019-12-18 |
| JP2020509403A (ja) | 2020-03-26 |
| JP7177073B2 (ja) | 2022-11-22 |
| CN111465882B (zh) | 2023-05-26 |
| WO2018148471A3 (fr) | 2018-10-04 |
| EP3580597A4 (fr) | 2021-05-05 |
| WO2018148471A2 (fr) | 2018-08-16 |
| CN111465882A (zh) | 2020-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11463608B2 (en) | Image-based assay using mark-assisted machine learning | |
| CN111465882B (zh) | 用于测定的光学器件、装置和系统 | |
| JP7084959B2 (ja) | 試料、特に血液を分析するための装置及びシステム、並びにそれらの使用方法 | |
| US20200302603A1 (en) | Method of computing tumor spatial and inter-marker heterogeneity | |
| US11842483B2 (en) | Systems for cell shape estimation | |
| US20220407988A1 (en) | Image-Based Assay Using Mark-Assisted Machine Learning | |
| US10083340B2 (en) | Automated cell segmentation quality control | |
| US11885952B2 (en) | Optics, device, and system for assaying and imaging | |
| CN112689757A (zh) | 使用crof和机器学习的基于图像测定的系统和方法 | |
| US20070135999A1 (en) | Method, apparatus and system for characterizing pathological specimen | |
| JP2018502279A (ja) | 組織学画像中の核の分類 | |
| JP2021501321A (ja) | 組織および細胞染色のためのデバイスおよび方法 | |
| US11906432B2 (en) | Enhanced, rapid, homogeneous, cell staining and assay | |
| WO2009063185A1 (fr) | Méthode et appareil de lecture de résultats | |
| Dolled-Filhart et al. | Automated analysis of tissue microarrays | |
| US20220065795A1 (en) | System and methods for remote assessment of a sample assay for disease diagnostics | |
| US20090041633A1 (en) | Apparatus and method for performing ligand binding assays on microarrays in multiwell plates | |
| US7867783B2 (en) | Apparatus and method for performing ligand binding assays on microarrays in multiwell plates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220920 |
|
| EEER | Examination request |
Effective date: 20220920 |
|
| EEER | Examination request |
Effective date: 20220920 |
|
| EEER | Examination request |
Effective date: 20220920 |
|
| EEER | Examination request |
Effective date: 20220920 |
|
| EEER | Examination request |
Effective date: 20220920 |